Search
for

    Learn

    0 / 0 results
    — no results

    Research

    5 / 54 results
      Table 1

      research Table 1

      December 2021
      Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.
      Table 2

      research Table 2

      December 2021
      Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.
      Cancer Chemotherapy: An Introduction

      research Cancer Chemotherapy: An Introduction

      4 citations, January 1977
      The book concludes that despite progress, cancer drug treatments have not met the expectations set in the 1960s and 1970s.
      Mucocutaneous Reactions to Chemotherapy

      research Mucocutaneous Reactions to Chemotherapy

      275 citations, March 1999 in “Journal of The American Academy of Dermatology”
      Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

    Community Join

    0 / 0 results
    — no results